{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:32:29Z","timestamp":1791952349945,"version":"4.3.4"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"DOI":"10.1093\/cid\/cit173","type":"journal-article","created":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T04:52:47Z","timestamp":1363755167000},"page":"147-155","source":"Crossref","is-referenced-by-count":46,"title":["Cytomegalovirus Viremia in Thai HIV-Infected Patients on Antiretroviral Therapy: Prevalence and Associated Mortality"],"prefix":"10.1093","volume":"57","author":[{"given":"Nicolas","family":"Durier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintanat","family":"Ananworanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanakorn","family":"Apornpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasiwimol","family":"Ubolyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apicha","family":"Mahanontharit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Ferradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiat","family":"Ruxrungtham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchalee","family":"Avihingsanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,3,19]]},"reference":[{"key":"key\n\t\t\t\t20170623065724_CIT173C1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s10096-004-1160-2","article-title":"Retinal and extra ocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994\u20132001","volume":"23","author":"Yust","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170623065724_CIT173C2","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents","volume-title":"MMWR Morb Mortal Wkly Rep","author":"Centers for Disease Control and Prevention","year":"2009"},{"key":"key\n\t\t\t\t20170623065724_CIT173C3","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ophtha.2006.11.008","article-title":"Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment","volume":"114","author":"Jabs","year":"2007","journal-title":"Ophthalmology"},{"key":"key\n\t\t\t\t20170623065724_CIT173C4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"key\n\t\t\t\t20170623065724_CIT173C5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJM199707103370207","article-title":"Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome","volume":"337","author":"Jacobson","year":"1997","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170623065724_CIT173C6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1023\/A:1007627508918","article-title":"Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986\u20131997. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA)","volume":"16","author":"Binquet","year":"2000","journal-title":"Eur J Epidemiol"},{"key":"key\n\t\t\t\t20170623065724_CIT173C7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ajo.2011.11.014","article-title":"Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"153","author":"Sugar","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"key\n\t\t\t\t20170623065724_CIT173C8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s15010-005-5050-z","article-title":"Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy","volume":"33","author":"Salzberger","year":"2005","journal-title":"Infection"},{"key":"key\n\t\t\t\t20170623065724_CIT173C9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ophtha.2004.10.049","article-title":"Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy","volume":"112","author":"Jabs","year":"2005","journal-title":"Ophthalmology"},{"key":"key\n\t\t\t\t20170623065724_CIT173C10","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1086\/379077","article-title":"Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome","volume":"37","author":"Kempen","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623065724_CIT173C11","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/00002030-199908200-00009","article-title":"Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group","volume":"13","author":"Casado","year":"1999","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170623065724_CIT173C12","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00002030-200005260-00017","article-title":"Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy","volume":"14","author":"Salmon-C\u00e9ron","year":"2000","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170623065724_CIT173C13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/375843","article-title":"Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360)","volume":"37","author":"Erice","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623065724_CIT173C14","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(04)16500-8","article-title":"Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy","volume":"363","author":"Deayton","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170623065724_CIT173C15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.qai.0000155204.96973.c3","article-title":"Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies","volume":"38","author":"Wohl","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170623065724_CIT173C16","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1371\/journal.pmed.0040334","article-title":"Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic","volume":"4","author":"Heiden","year":"2007","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20170623065724_CIT173C17","first-page":"399","article-title":"Epidemiology of the ocular complications of HIV infection in Chiang Mai","volume":"86","author":"Ausayakhun","year":"2003","journal-title":"J Med Assoc Thai"},{"key":"key\n\t\t\t\t20170623065724_CIT173C18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9394(99)00415-8","article-title":"Ocular lesions associated with HIV infection in India: a series of 100 consecutive patients evaluated at a referral center","volume":"129","author":"Biswas","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"key\n\t\t\t\t20170623065724_CIT173C19","article-title":"Stability analysis of cytomegalovirus (CMV) and Epstein-Bar virus (EBV) viral load in whole blood sample stored at different temperatures for varied duration. (Abstract M10)","author":"Pang","year":"2010"},{"key":"key\n\t\t\t\t20170623065724_CIT173C20","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/JCM.02447-10","article-title":"Stability of hepatitis C virus, HIV, and hepatitis B virus nucleic acids in plasma samples after long-term storage at \u221220\u00b0C and \u221270\u00b0C","volume":"49","author":"Baleriola","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170623065724_CIT173C21","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00002030-199907090-00008","article-title":"Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy","volume":"13","author":"Deayton","year":"1999","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170623065724_CIT173C22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/QAI.0b013e3181a254c2","article-title":"Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004\u20132007)","volume":"51","author":"Micol","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170623065724_CIT173C23","doi-asserted-by":"crossref","first-page":"e25571","DOI":"10.1371\/journal.pone.0025571","article-title":"Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa","volume":"6","author":"Fielding","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170623065724_CIT173C24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00002030-199707000-00008","article-title":"Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease","volume":"11","author":"Bowen","year":"1997","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170623065724_CIT173C25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1468-1293.2010.00900.x","article-title":"Clinical relevance of cytomegalovirus viraemia","volume":"12","author":"El Amari","year":"2011","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170623065724_CIT173C26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI1101","article-title":"Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients","volume":"101","author":"Spector","year":"1998","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170623065724_CIT173C27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1086\/314936","article-title":"Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival","volume":"180","author":"Emery","year":"1999","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170623065724_CIT173C28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(88)90014-1","article-title":"Value of necropsy in acquired immunodeficiency syndrome","volume":"2","author":"Wilkes","year":"1988","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170623065724_CIT173C29","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00002030-199307000-00010","article-title":"A clinico-pathological audit of opportunistic viral infections in HIV-infected patients","volume":"7","author":"Pillay","year":"1993","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170623065724_CIT173C30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1445-5994.1995.tb01495.x","article-title":"Clinico-pathological study of cytomegalovirus (CMV) in AIDS autopsies: under-recognition of CMV pneumonitis and CMV adrenalitis","volume":"25","author":"Dore","year":"1995","journal-title":"Aust N Z J Med"},{"key":"key\n\t\t\t\t20170623065724_CIT173C31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/00365540110076976","article-title":"CMV disease in AIDS patients: incidence of CMV disease and relation to survival in a population-based study from Oslo","volume":"34","author":"Brantsaeter","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"key\n\t\t\t\t20170623065724_CIT173C32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1378\/chest.92.2.198","article-title":"Cytomegalovirus pneumonitis in patients with AIDS: findings in an autopsy series","volume":"92","author":"Wallace","year":"1987","journal-title":"Chest"},{"key":"key\n\t\t\t\t20170623065724_CIT173C33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1758-2652-14-41","article-title":"CMV retinitis screening and treatment in a resource-poor setting: three-year experience from a primary care HIV\/AIDS programme in Myanmar","volume":"14","author":"Tun","year":"2011","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20170623065724_CIT173C34","first-page":"1042","article-title":"Cytomegalovirus retinitis and ocular complications in AIDS patients in Togo","volume":"22","author":"Balo","year":"1999","journal-title":"J Fr Ophthalmol"},{"key":"key\n\t\t\t\t20170623065724_CIT173C35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.iae.0000249575.38830.45","article-title":"Blindness and low vision in a tertiary ophthalmologic center in Thailand: the importance of cytomegalovirus retinitis","volume":"27","author":"Pathanapitoon","year":"2007","journal-title":"Retina"},{"issue":"suppl 2","key":"key\n\t\t\t\t20170623065724_CIT173C36","doi-asserted-by":"crossref","first-page":"i33","DOI":"10.1136\/sextrans-2012-050658","article-title":"Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy","volume":"88","author":"Yiannoutsos","year":"2012","journal-title":"Sex Transm Infect"},{"key":"key\n\t\t\t\t20170623065724_CIT173C37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/QAI.0b013e3182821821","article-title":"Mortality, AIDS-morbidity and loss to follow-up by current CD4 cell count among HIV-1 infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration","volume":"62","author":"Gabillard","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170623065724_CIT173C38","article-title":"Immunodeficiency at the Start of ART: Global View (Abstract 100)","author":"Mugglin","year":"2012"},{"key":"key\n\t\t\t\t20170623065724_CIT173C39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1310\/hct1003-143","article-title":"Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030","volume":"10","author":"Wohl","year":"2009","journal-title":"HIV Clin Trials"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/57\/1\/147\/17854049\/cit173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T21:47:14Z","timestamp":1503438434000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cit173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,3,19]]},"published-print":{"date-parts":[[2013,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cit173","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,19]]}}}